Hap Trading, LLC Amicus Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $95,254 - $123,675	9,700 Added 72.93%	23,000 $14,000
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $4,361 - $7,783	700 Added 5.56%	13,300 $7,000
Q1 2022 May 12, 2022	BUY	$7.89 - $12.48 $17,358 - $27,456	2,200 Added 21.15%	12,600 $6,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $49,100 - $62,200	-5,000 Reduced 32.47%	10,400 $4,000
Q3 2021 Nov 10, 2021	SELL	$8.74 - $11.84 $55,936 - $75,776	-6,400 Reduced 29.36%	15,400 $5,000
Q2 2021 Aug 11, 2021	SELL	$8.71 - $10.72 $9,581 - $11,792	-1,100 Reduced 4.8%	21,800 $6,000
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $113,159 - $293,478	12,300 Added 116.04%	22,900 $6,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $142,782 - $263,834	10,600 New	10,600 $70,000
Q4 2019 Feb 11, 2020	SELL	$7.48 - $10.75 $104,720 - $150,500	-14,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $112,280 - $185,500	14,000 New	14,000 $5,000
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $406,616 - $534,240	-37,100 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$10.04 - $13.92 $254,011 - $352,176	25,300 Added 214.41%	37,100 $38,000
Q4 2018 Feb 12, 2019	BUY	$8.38 - $13.44 $98,884 - $158,592	11,800 New	11,800 $5,000
Q3 2018 Nov 09, 2018	SELL	$11.6 - $16.54 $229,680 - $327,492	-19,800 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$13.13 - $17.09 $330,876 - $430,668	-25,200 Reduced 56.0%	19,800 $8,000
Q1 2018 May 11, 2018	SELL	$13.76 - $17.12 $1,376 - $1,712	-100 Reduced 0.22%	45,000 $8,000
Q4 2017 Feb 09, 2018	BUY	$12.51 - $16.24 $564,201 - $732,423	45,100	45,100 $25,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.